The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype

Hanne Meijers-Heijboer; Juul Wijnen; Hans Vasen; Marijke Wasielewski; Anja Wagner; Antoinette Hollestelle; Fons Elstrodt; Renate Van Den Bos; Anja De Snoo; Grace Tjon A. Fat; Cecile Brekelmans; Shantie Jagmohan; Patrick Franken; Paul Verkuijlen; Ans Van Den Ouweland; Pamela Chapman; Carli Tops; Gabriela Möslein; John Burn; Henry Lynch; Jan Klijn; Riccardo Fodde; Mieke Schutte

doi:10.1086/375121

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype

Hanne Meijers-Heijboer, Juul Wijnen, Hans Vasen, Marijke Wasielewski, Anja Wagner, Antoinette Hollestelle, Fons Elstrodt, Renate Van Den Bos, Anja De Snoo, Grace Tjon A. Fat, Cecile Brekelmans, Shantie Jagmohan, Patrick Franken, Paul Verkuijlen, Ans Van Den Ouweland, Pamela Chapman, Carli Tops, Gabriela Möslein, John Burn, Henry LynchJan Klijn, Riccardo Fodde, Mieke Schutte

Department of Preventive Medicine

Research output: Contribution to journal › Article

162 Scopus citations

Abstract

Because of genetic heterogeneity, the identification of breast cancer-susceptibility genes has proven to be exceedingly difficult. Here, we define a new subset of families with breast cancer characterized by the presence of colorectal cancer cases. The 1100delC variant of the cell cycle checkpoint kinase CHEK2 gene was present in 18% of 55 families with hereditary breast and colorectal cancer (HBCC) as compared with 4% of 380 families with non-HBCC (P <.001), thus providing genetic evidence for the HBCC phenotype. The CHEK2 1100delC mutation was, however, not the major predisposing factor for the HBCC phenotype but appeared to act in synergy with another, as-yet-unknown susceptibility gene(s). The unequivocal definition of the HBCC phenotype opens new avenues to search for this putative HBCC-susceptibility gene.

Original language	English (US)
Pages (from-to)	1308-1314
Number of pages	7
Journal	American journal of human genetics
Volume	72
Issue number	5
DOIs	https://doi.org/10.1086/375121
State	Published - May 1 2003

All Science Journal Classification (ASJC) codes

Genetics
Genetics(clinical)

Access to Document

10.1086/375121

Fingerprint Dive into the research topics of 'The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype'. Together they form a unique fingerprint.

Cite this

Meijers-Heijboer, H., Wijnen, J., Vasen, H., Wasielewski, M., Wagner, A., Hollestelle, A., Elstrodt, F., Van Den Bos, R., De Snoo, A., Fat, G. T. A., Brekelmans, C., Jagmohan, S., Franken, P., Verkuijlen, P., Van Den Ouweland, A., Chapman, P., Tops, C., Möslein, G., Burn, J., ... Schutte, M. (2003). The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. American journal of human genetics, 72(5), 1308-1314. https://doi.org/10.1086/375121

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. / Meijers-Heijboer, Hanne; Wijnen, Juul; Vasen, Hans; Wasielewski, Marijke; Wagner, Anja; Hollestelle, Antoinette; Elstrodt, Fons; Van Den Bos, Renate; De Snoo, Anja; Fat, Grace Tjon A.; Brekelmans, Cecile; Jagmohan, Shantie; Franken, Patrick; Verkuijlen, Paul; Van Den Ouweland, Ans; Chapman, Pamela; Tops, Carli; Möslein, Gabriela; Burn, John; Lynch, Henry; Klijn, Jan; Fodde, Riccardo; Schutte, Mieke.

In: American journal of human genetics, Vol. 72, No. 5, 01.05.2003, p. 1308-1314.

Research output: Contribution to journal › Article

Meijers-Heijboer, H, Wijnen, J, Vasen, H, Wasielewski, M, Wagner, A, Hollestelle, A, Elstrodt, F, Van Den Bos, R, De Snoo, A, Fat, GTA, Brekelmans, C, Jagmohan, S, Franken, P, Verkuijlen, P, Van Den Ouweland, A, Chapman, P, Tops, C, Möslein, G, Burn, J, Lynch, H, Klijn, J, Fodde, R & Schutte, M 2003, 'The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype', American journal of human genetics, vol. 72, no. 5, pp. 1308-1314. https://doi.org/10.1086/375121

Meijers-Heijboer, Hanne ; Wijnen, Juul ; Vasen, Hans ; Wasielewski, Marijke ; Wagner, Anja ; Hollestelle, Antoinette ; Elstrodt, Fons ; Van Den Bos, Renate ; De Snoo, Anja ; Fat, Grace Tjon A. ; Brekelmans, Cecile ; Jagmohan, Shantie ; Franken, Patrick ; Verkuijlen, Paul ; Van Den Ouweland, Ans ; Chapman, Pamela ; Tops, Carli ; Möslein, Gabriela ; Burn, John ; Lynch, Henry ; Klijn, Jan ; Fodde, Riccardo ; Schutte, Mieke. / The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. In: American journal of human genetics. 2003 ; Vol. 72, No. 5. pp. 1308-1314.

@article{0a382a02ec6a4260882e2cf73349da0a,

title = "The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype",

abstract = "Because of genetic heterogeneity, the identification of breast cancer-susceptibility genes has proven to be exceedingly difficult. Here, we define a new subset of families with breast cancer characterized by the presence of colorectal cancer cases. The 1100delC variant of the cell cycle checkpoint kinase CHEK2 gene was present in 18% of 55 families with hereditary breast and colorectal cancer (HBCC) as compared with 4% of 380 families with non-HBCC (P <.001), thus providing genetic evidence for the HBCC phenotype. The CHEK2 1100delC mutation was, however, not the major predisposing factor for the HBCC phenotype but appeared to act in synergy with another, as-yet-unknown susceptibility gene(s). The unequivocal definition of the HBCC phenotype opens new avenues to search for this putative HBCC-susceptibility gene.",

author = "Hanne Meijers-Heijboer and Juul Wijnen and Hans Vasen and Marijke Wasielewski and Anja Wagner and Antoinette Hollestelle and Fons Elstrodt and {Van Den Bos}, Renate and {De Snoo}, Anja and Fat, {Grace Tjon A.} and Cecile Brekelmans and Shantie Jagmohan and Patrick Franken and Paul Verkuijlen and {Van Den Ouweland}, Ans and Pamela Chapman and Carli Tops and Gabriela M{\"o}slein and John Burn and Henry Lynch and Jan Klijn and Riccardo Fodde and Mieke Schutte",

year = "2003",

month = may,

day = "1",

doi = "10.1086/375121",

language = "English (US)",

volume = "72",

pages = "1308--1314",

journal = "American Journal of Human Genetics",

issn = "0002-9297",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype

AU - Meijers-Heijboer, Hanne

AU - Wijnen, Juul

AU - Vasen, Hans

AU - Wasielewski, Marijke

AU - Wagner, Anja

AU - Hollestelle, Antoinette

AU - Elstrodt, Fons

AU - Van Den Bos, Renate

AU - De Snoo, Anja

AU - Fat, Grace Tjon A.

AU - Brekelmans, Cecile

AU - Jagmohan, Shantie

AU - Franken, Patrick

AU - Verkuijlen, Paul

AU - Van Den Ouweland, Ans

AU - Chapman, Pamela

AU - Tops, Carli

AU - Möslein, Gabriela

AU - Burn, John

AU - Lynch, Henry

AU - Klijn, Jan

AU - Fodde, Riccardo

AU - Schutte, Mieke

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Because of genetic heterogeneity, the identification of breast cancer-susceptibility genes has proven to be exceedingly difficult. Here, we define a new subset of families with breast cancer characterized by the presence of colorectal cancer cases. The 1100delC variant of the cell cycle checkpoint kinase CHEK2 gene was present in 18% of 55 families with hereditary breast and colorectal cancer (HBCC) as compared with 4% of 380 families with non-HBCC (P <.001), thus providing genetic evidence for the HBCC phenotype. The CHEK2 1100delC mutation was, however, not the major predisposing factor for the HBCC phenotype but appeared to act in synergy with another, as-yet-unknown susceptibility gene(s). The unequivocal definition of the HBCC phenotype opens new avenues to search for this putative HBCC-susceptibility gene.

AB - Because of genetic heterogeneity, the identification of breast cancer-susceptibility genes has proven to be exceedingly difficult. Here, we define a new subset of families with breast cancer characterized by the presence of colorectal cancer cases. The 1100delC variant of the cell cycle checkpoint kinase CHEK2 gene was present in 18% of 55 families with hereditary breast and colorectal cancer (HBCC) as compared with 4% of 380 families with non-HBCC (P <.001), thus providing genetic evidence for the HBCC phenotype. The CHEK2 1100delC mutation was, however, not the major predisposing factor for the HBCC phenotype but appeared to act in synergy with another, as-yet-unknown susceptibility gene(s). The unequivocal definition of the HBCC phenotype opens new avenues to search for this putative HBCC-susceptibility gene.

UR - http://www.scopus.com/inward/record.url?scp=0038406108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038406108&partnerID=8YFLogxK

U2 - 10.1086/375121

DO - 10.1086/375121

M3 - Article

C2 - 12690581

AN - SCOPUS:0038406108

VL - 72

SP - 1308

EP - 1314

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 5

ER -